Locals Flashcards
Lidocaine
Amide Local Anesthetic Anti-arrhythmic class 1B
Use;
- regional anesthesia to block transmission of nerve signals to prove analgesia without loss of consciousness
- ACLS pathway for pulseless VFib and VT
- attenuates the response to intubation
- post op IV dose; analgesia to decrease opioid use
MOA; Blocks VGNaChannel in nerve cell membrane while in closed inactive state; prevents depolarization and impulse transmission
Anti-arrhythmic MOA;
- blocking of Na channels in cardiomyocytes by monoethylglycinexylidide
- shortens the action potential duration and refractory period preventing reentry dysrhythmias such as PVCs and VT
Dose;
Blunt SNS response; 1 mg/kg
Arrhythmias; 2 mg/kg followed by infusion 1 - 4 mg/min
ACLs; 1.5 mg/kg q 3 - 5 min to max of 3 mg/kg
LA max dose 4 mg/kg or 7mg/kg with epi
Spinal; 1 - 2 ml or 30 - 100 mg
Pharmacokinetics;
-onset; Rapid
- E1/2 time; 90 min (up to 8 hours for active metabolite)
- DOA; 1 - 2 hours (increase DOA with epi)
- Vd; 91 L
- Pb; 65- 70% (LA)
- Pb; 55% (anti arrhythmic)
- metabolized by liver via CYP450 system
- metabolism is BF dependent (propranolol, VA and cimetidine can decrease clearance)
- pt at risk for toxic build up in liver failure
*active metabolite; monoethylglycinexylidide then hydrolyzed to xylidine
Monoethy; E1/2t is longer *anti-arrhythmic
Elimination; very little excreted unchanged by the kidneys
Side Effects;
-allergic reactions are rare with amide LA
- TNS (transient neurological symptoms); neuroinflamm in buttock, lower back, post thighs 3-6 hrs after recovery
- Cauda equina syndrome; diffuse lumbosacral injury, can cause paraplegia w/ 5% Lido
Lidocaine;
> 5 mcg/ml Systemic toxicity begins at plasma conc.
may result in prolonged P-R interval and QRS complex
- 5-10 mcg/ml: LA toxicity circumoral numbness, lightheadedness, tinnitus, skeletal muscle twitching, visual disturbances, tachycardia, systemic hypotension, myocardial depression, decreased SVR, cardiac output.
- 10-15 mcg/ml: seizures, unconsciousness
- 15-25 mcg/ml: apnea, coma
Contraindications;- Coagulopathy
- infection
- hypovolemia
- hypersensitivity
caution in impaired hepatic function; decrease dose
Bupivacaine
Amide Local Anesthetic
MOA; hold VGNa channel in closed inactive state and prevents depolarization and impulse transmission
Uses; Regional anesthesia; provides analgesia without LOC
- good differential nerve block
- epidural, spinal, OB
LA max Dose; 2.5 mg/kg
Spinal; 2 - 3 ml or 15 - 20 mg
Pharmacokinetics;
- Onset; moderate
- E1/2 time; 3.5 hours
- DOA; long
- Pb; 95%
- high lipid solubility (30)
- Pka; 8.1
- % nonionized; 17
metabolism; CYP450 enzymes; blood flow dependent (propranolol, VA and cimetidine decrease clearance)
*decrease dose in liver failure; risk of toxic build up
Side effects;
- minimal. risk of anaphylaxis (> risk with Ester LA)
- LA toxicity; circumoral numbness, lightheadedness, vision changes, ringing in ears, slurred speech; leads to CNS changes, seizure, apnea
- Transient neurological symptoms (TNS)
- cauda equina syndrome
- myocardial depression, increased HR, decreased BP, SVR, CO
- *bupivacaine is the most CV toxic r/t affinity for receptors
Contraindication; infection, coagulopathy, hypovolemia,
Cocaine
Ester Local Anesthetic
Uses;
- Ophthalmic & ENT surgery to cause vasoconstriction and reduce bleeding
- topical anesthetic used for suturing small cuts
MOA;
- blocks the VGNA channels in the closed inactive state and block initiation and conduction of nerve impulses by deceasing the membranes permeability to sodium ions; blocking depolarization
- blocks uptake of NE; producing vasoconstriction, tachycardia and HTN
Max Dose; 1.5 - 3 mg/kg
Pharmacokinetics;
- onset; 1 min
- peak; 5 min
- E1/2t; 75 min
- DOA; dose dependent (>30min)
metabolized by plasma and liver cholinesterase
10% excreted unchanged in the urine
*CYP450 INHIBITOR
Side Effects;
- CV toxicity (small doses; Bradycardia/large doses tachycardia)
- HTN
- V Tach/ V-Fib
- Myocardial depression
- cardiac arrest
- Tachyphylaxis (recreational use can have implication on effects of ketamine, ephedrine)
Contraindications;
- CAD
- MI
- CHF
- arrhythmias
- HTN
- MAOi
- Pregnancy
Caution
-decreased plasma cholinesterase activity